Professor of Medicine, Temple University
Oncology
Dr. Lori J. Goldstein, MD
|
|
Give Review
Lori Goldstein works in the field of Oncology. She went to medical school at State University of New York Upstate Medical University. She received awards:"Philadelphia Magazine", "America's Top Doctors", "America's Top Doctors for Cancer", "Fellow (FASCO)" and "Redbook Magazine: Top Breast Cancer Doctors". Lori Goldstein is a published physician. She has 40 papers published. The most current publication "Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy."
Publications
- Multifocal and Multicentric Breast Cancer is Associated with Increased Local Recurrence Regardless of Surgery Type.
- Goserelin for ovarian protection during breast-Cancer adjuvant chemotherapy.
- Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience.
- Risk of Positive Nonsentinel Nodes in Women with 1-2 Positive Sentinel Nodes Related to Age and Molecular Subtype Approximated by Receptor Status.
- Reducing the time from initial call to first appointment: the impact of patient access redesign and a nurse navigation program.
- How Do I Follow Patients With Early Breast Cancer After Completing Adjuvant Therapy.
- Breast Cancer, Version 3.2013.
- Survival in patients with metastatic recurrent breast Cancer after adjuvant chemotherapy: Little evidence of improvement over the past 30 years.
- Identifying patients who may be candidates for a clinical trial of salvage accelerated partial Breast irradiation after previous whole Breast irradiation.
- Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer.
- Lymphatic Space Invasion is Not an Independent Predictor of Outcomes in Early Stage Breast Cancer Treated by Breast-Conserving Surgery and Radiation.
- Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer.
- Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study.
- Invasive breast Cancer.
- Breast Cancer: noninvasive and special situations.
- Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation.
- History of smoking is associated with younger age at diagnosis of breast Cancer.
- Optimizing chemotherapy regimens for patients with early-stage breast Cancer.
- Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.
- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.
- Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast Cancer with 0 to 3 positive axillary n...
- Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast Cancer compared with classical clinicopathologic features.
- A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced Cancer.
- Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription po...
- Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer.
- NCCN Task Force Report: breast Cancer in the older woman.
- Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative.
- Four-week course of radiation for breast Cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
- Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast Cancer.
- Controversies in adjuvant endocrine treatment of premenopausal women.
- American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-posit...
- Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant Malignancies.
- Prognostic and predictive factors in early-stage breast Cancer.
- Routine mammography is associated with earlier stage disease and greater eligibility for Breast conservation in Breast carcinoma patients age 40 years and older.
- American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
- Taxanes in the adjuvant treatment of breast Cancer.
- Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primar...
- American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive Breast canc...
- Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast Cancer.
Schools
SUNY Upstate Medical University Syracuse
Presby University Hospital
NciNih
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Breast Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FASCO)
- Redbook Magazine: Top Breast Cancer Doctors
Education
-
National Institutes of Health Clinical Center -
University of Pittsburgh Medical Center -
State University of New York Upstate Medical University -
University of Pennsylvania
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Helpful Reviews
Similar Doctors
|
Dr. Emmanuel C. Besa, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Marijo Bilusic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela R. Bradbury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charlotte E. Gauwerky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elena Gitelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger B. Cohen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|